false 0001124804 0001124804 2020-05-21 2020-05-21

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): May 21, 2020

 

ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

 

001-35547

 

36-4392754

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

222 Merchandise Mart Plaza, Suite 2024, Chicago, Illinois 60654

(Address of Principal Executive Offices) (Zip Code)

Registrant’s Telephone Number, Including Area Code: (800) 334-8534

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

 

Trading

Symbol

 

Name of Each Exchange

on which Registered

Common Stock, par value $0.01 per share

 

MDRX

 

The Nasdaq Stock Market LLC

(Nasdaq Global Select Market)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

At the Annual Meeting of Stockholders of Allscripts Healthcare Solutions, Inc. (the “Company”) held on May 21, 2020, the stockholders of the Company approved the amendment and restatement of the Allscripts Healthcare Solutions, Inc. 2019 Stock Incentive Plan (as amended and restated, the “Amended and Restated 2019 Stock Incentive Plan”). The amendment and restatement increases the available shares under the Amended and Restated 2019 Stock Incentive Plan by 3,900,000 shares. The foregoing summary is qualified in its entirety by reference to the complete text of the Amended and Restated 2019 Stock Incentive Plan, a copy of which is included as Exhibit 10.1 hereto and is incorporated by reference herein.

Item 5.07 Submission of Matters to a Vote of Security Holders.

At the Annual Meeting of Stockholders of the Company held on May 21, 2020 (the “2020 Annual Meeting”), the stockholders of the Company voted on the following five proposals and cast their votes as described below:

1. The individuals listed below were elected at the 2020 Annual Meeting to serve as directors of the Company until the next annual meeting of stockholders and until their successors are duly elected and qualified.

 

For

   

Against

   

Abstain

   

Broker Non-Vote

 

Mara G. Aspinall

   

122,508,727

     

22,464,538

     

156,447

     

9,693,772

 

Paul M. Black

   

123,502,689

     

21,531,332

     

95,691

     

9,693,772

 

P. Gregory Garrison

   

123,595,810

     

21,373,887

     

160,015

     

9,693,772

 

Jonathan J. Judge

   

106,646,204

     

38,326,054

     

157,454

     

9,693,772

 

Michael A. Klayko

   

106,972,448

     

38,004,415

     

152,849

     

9,693,772

 

Dave B. Stevens

   

122,104,819

     

22,872,134

     

152,759

     

9,693,772

 

David D. Stevens

   

107,455,077

     

37,519,716

     

154,919

     

9,693,772

 

2. A management proposal to approve an amendment and restatement of the Allscripts Healthcare Solutions, Inc. 2019 Stock Incentive Plan to increase the number of shares available for grant thereunder, as described in the Company’s proxy materials, was approved.

For

 

Against

 

Abstain

 

Broker Non-Vote

139,798,399

 

3,489,464

 

1,841,849

 

9,693,772

3. A management proposal to approve an amendment and restatement of the Allscripts Healthcare Solutions, Inc. Employee Stock Purchase Plan to increase the number of shares available for grant thereunder and to extend the expiration date of the plan, as described in the Company’s proxy materials, was approved.

For

 

Against

 

Abstain

 

Broker Non-Vote

144,107,945

 

874,715

 

147,052

 

9,693,772

4. A management proposal to ratify the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2020, as described in the Company’s proxy materials, was approved.

For

 

Against

 

Abstain

 

Broker Non-Vote

153,531,583

 

883,296

 

408,605

 

0

5. A non-binding, advisory resolution to approve the Company’s named executive officer compensation, as described in the Company’s proxy materials, was approved.

For

 

Against

 

Abstain

 

Broker Non-Vote

137,617,265

 

7,239,562

 

272,885

 

9,693,772


Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

   

 

   

Incorporated by Reference

 

Exhibit
Number

   

Exhibit Description

 

Filed
Herewith

   

Form

   

Exhibit

   

Filing Date

 
                                         
 

10.1

   

Allscripts Healthcare Solutions, Inc. Amended and Restated 2019 Stock Incentive Plan

   

     

S-8

     

4.3

     

May 22, 2020

 
                                         
 

104

   

Cover Page Interactive Data File (embedded within the Inline XBRL document)

   

X

     

     

     

 


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.

             

Date: May 22, 2020

 

 

By:

 

/s/ Brian P. Farley

 

 

 

Brian P. Farley

 

 

 

Executive Vice President, Chief Administrative Officer,

General Counsel and Corporate Secretary

Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Veradigm Charts.
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Veradigm Charts.